1. Home
  2. SHPH vs CISS Comparison

SHPH vs CISS Comparison

Compare SHPH & CISS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHPH
  • CISS
  • Stock Information
  • Founded
  • SHPH 2012
  • CISS 2022
  • Country
  • SHPH United States
  • CISS Greece
  • Employees
  • SHPH N/A
  • CISS N/A
  • Industry
  • SHPH Biotechnology: Pharmaceutical Preparations
  • CISS Marine Transportation
  • Sector
  • SHPH Health Care
  • CISS Consumer Discretionary
  • Exchange
  • SHPH Nasdaq
  • CISS Nasdaq
  • Market Cap
  • SHPH 2.3M
  • CISS 2.5M
  • IPO Year
  • SHPH 2022
  • CISS N/A
  • Fundamental
  • Price
  • SHPH $3.58
  • CISS $2.22
  • Analyst Decision
  • SHPH
  • CISS
  • Analyst Count
  • SHPH 0
  • CISS 0
  • Target Price
  • SHPH N/A
  • CISS N/A
  • AVG Volume (30 Days)
  • SHPH 26.8K
  • CISS 302.8K
  • Earning Date
  • SHPH 08-13-2025
  • CISS 09-02-2025
  • Dividend Yield
  • SHPH N/A
  • CISS N/A
  • EPS Growth
  • SHPH N/A
  • CISS N/A
  • EPS
  • SHPH N/A
  • CISS 5.74
  • Revenue
  • SHPH N/A
  • CISS $38,084,901.00
  • Revenue This Year
  • SHPH N/A
  • CISS N/A
  • Revenue Next Year
  • SHPH N/A
  • CISS N/A
  • P/E Ratio
  • SHPH N/A
  • CISS $0.38
  • Revenue Growth
  • SHPH N/A
  • CISS N/A
  • 52 Week Low
  • SHPH $3.00
  • CISS $2.03
  • 52 Week High
  • SHPH $56.25
  • CISS $18.75
  • Technical
  • Relative Strength Index (RSI)
  • SHPH 53.68
  • CISS 30.03
  • Support Level
  • SHPH $3.34
  • CISS $2.03
  • Resistance Level
  • SHPH $3.67
  • CISS $3.80
  • Average True Range (ATR)
  • SHPH 0.20
  • CISS 0.15
  • MACD
  • SHPH 0.04
  • CISS -0.06
  • Stochastic Oscillator
  • SHPH 80.58
  • CISS 17.78

About SHPH Shuttle Pharmaceuticals Holdings Inc.

Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.

About CISS C3is Inc.

C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including major national and private industrial users, commodity producers and traders. The company owns and operates a fleet of two dry bulk carriers that transport major bulks such as iron ore, coal and grains, and minor bulks such as bauxite, phosphate and fertilizers. The total cargo-carrying capacity of our fleet is approximately 64,000 dwt.

Share on Social Networks: